{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82022",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "111 S Calvert St Fl 21ST",
      "address_2": "",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States.",
      "recall_number": "D-0429-2019",
      "product_description": "Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles, Rx only, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA.",
      "product_quantity": "9,930 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.",
      "recall_initiation_date": "20190128",
      "center_classification_date": "20190205",
      "termination_date": "20200622",
      "report_date": "20190213",
      "code_info": "a) H804506 Exp. 06/2020; 803555 Exp. 04/2020; H805394, Exp. 08/2020  b) H804112 Exp. 05/2020; H803220 Exp. 03/2020",
      "more_code_info": ""
    }
  ]
}